ITUS Announces Cchek(TM) Preliminary Cancer Patient Efficacy Study Results
LOS ANGELES, CA--(Marketwired - December 07, 2016) - ITUS Corporation ("ITUS") (NASDAQ: ITUS), today announced preliminary results from its Cchek™ cancer patient efficacy study. Using its most recent protocols and methods for measuring a patient…